1. Home
  2. THTX vs SEER Comparison

THTX vs SEER Comparison

Compare THTX & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THTX
  • SEER
  • Stock Information
  • Founded
  • THTX 1993
  • SEER 2017
  • Country
  • THTX Canada
  • SEER United States
  • Employees
  • THTX N/A
  • SEER 134
  • Industry
  • THTX Biotechnology: Pharmaceutical Preparations
  • SEER Medicinal Chemicals and Botanical Products
  • Sector
  • THTX Health Care
  • SEER Health Care
  • Exchange
  • THTX Nasdaq
  • SEER Nasdaq
  • Market Cap
  • THTX 118.2M
  • SEER 121.8M
  • IPO Year
  • THTX N/A
  • SEER 2020
  • Fundamental
  • Price
  • THTX $2.62
  • SEER $1.84
  • Analyst Decision
  • THTX Hold
  • SEER Hold
  • Analyst Count
  • THTX 1
  • SEER 1
  • Target Price
  • THTX N/A
  • SEER $3.00
  • AVG Volume (30 Days)
  • THTX 6.2M
  • SEER 174.6K
  • Earning Date
  • THTX 04-09-2025
  • SEER 05-13-2025
  • Dividend Yield
  • THTX N/A
  • SEER N/A
  • EPS Growth
  • THTX N/A
  • SEER N/A
  • EPS
  • THTX N/A
  • SEER N/A
  • Revenue
  • THTX $88,666,000.00
  • SEER $14,170,000.00
  • Revenue This Year
  • THTX N/A
  • SEER $23.54
  • Revenue Next Year
  • THTX $15.13
  • SEER $42.98
  • P/E Ratio
  • THTX N/A
  • SEER N/A
  • Revenue Growth
  • THTX 13.52
  • SEER N/A
  • 52 Week Low
  • THTX $1.08
  • SEER $1.56
  • 52 Week High
  • THTX $3.13
  • SEER $2.63
  • Technical
  • Relative Strength Index (RSI)
  • THTX 57.56
  • SEER 41.77
  • Support Level
  • THTX $2.64
  • SEER $1.88
  • Resistance Level
  • THTX $2.82
  • SEER $1.97
  • Average True Range (ATR)
  • THTX 0.17
  • SEER 0.10
  • MACD
  • THTX -0.04
  • SEER -0.02
  • Stochastic Oscillator
  • THTX 20.45
  • SEER 0.00

About THTX Theratechnologies Inc.

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.

About SEER Seer Inc.

Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.

Share on Social Networks: